(EDU) New Oriental Education - Overview
Stock: Tutoring, Consulting, E-commerce, Materials
| Risk 5d forecast | |
|---|---|
| Volatility | 47.3% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.36 |
| Alpha | 1.60 |
| Character TTM | |
|---|---|
| Beta | 0.229 |
| Beta Downside | 0.688 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.79% |
| CAGR/Max DD | 0.20 |
EPS (Earnings per Share)
Revenue
Description: EDU New Oriental Education March 04, 2026
New Oriental Education & Technology Group Inc. (EDU) provides private educational services in China. The company operates across four segments: Educational Services and Test Preparation, Private Label Products and Livestreaming E-Commerce, Overseas Study Consulting, and Educational Materials and Distribution.
EDU offers test preparation for language and entrance exams for institutions in the US, Commonwealth countries, and China. This includes non-academic tutoring and digital learning tools. The Chinese private education sector has undergone significant regulatory changes in recent years, impacting business models focused on academic tutoring.
The company also provides overseas study consulting and online education via Koolearn.com. Additionally, EDU develops educational materials. Their services are delivered through physical schools, learning centers, bookstores, and online platforms. Diversification into non-academic areas and e-commerce represents a strategic shift for many education providers in the region.
For more detailed financial analysis and performance metrics, consider exploring ValueRays comprehensive profiles.
Headlines to watch out for
- Chinas regulatory policies heavily impact private education sector
- Overseas study demand drives consulting service revenue
- Livestreaming e-commerce expands new revenue streams
- Test preparation course enrollment affects core business
- Digital learning platforms boost educational service accessibility
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 381.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 1.98 > 1.0 |
| NWC/Revenue: 39.54% < 20% (prev 46.44%; Δ -6.90% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.11b > Net Income 381.1m |
| Net Debt (-1.06b) to EBITDA (686.6m): -1.55 < 3 |
| Current Ratio: 1.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (160.5m) vs 12m ago -3.29% < -2% |
| Gross Margin: 55.33% > 18% (prev 0.53%; Δ 5480 % > 0.5%) |
| Asset Turnover: 64.59% > 50% (prev 63.11%; Δ 1.48% > 0%) |
| Interest Coverage Ratio: 1659 > 6 (EBITDA TTM 686.6m / Interest Expense TTM 311.0k) |
Altman Z'' 3.30
| A: 0.25 (Total Current Assets 5.59b - Total Current Liabilities 3.55b) / Total Assets 8.29b |
| B: 0.21 (Retained Earnings 1.77b / Total Assets 8.29b) |
| C: 0.06 (EBIT TTM 515.8m / Avg Total Assets 7.96b) |
| D: 0.54 (Book Value of Equity 2.19b / Total Liabilities 4.09b) |
| Altman-Z'' Score: 3.30 = A |
Beneish M -2.99
| DSRI: 0.98 (Receivables 42.9m/41.1m, Revenue 5.14b/4.82b) |
| GMI: 0.96 (GM 55.33% / 52.91%) |
| AQI: 1.24 (AQ_t 0.14 / AQ_t-1 0.11) |
| SGI: 1.07 (Revenue 5.14b / 4.82b) |
| TATA: -0.09 (NI 381.1m - CFO 1.11b) / TA 8.29b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of EDU shares?
Over the past week, the price has changed by +1.07%, over one month by -12.81%, over three months by -1.04% and over the past year by +11.37%.
Is EDU a buy, sell or hold?
- StrongBuy: 12
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the EDU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68.3 | 28.7% |
| Analysts Target Price | 68.3 | 28.7% |
EDU Fundamental Data Overview March 11, 2026
P/E Forward = 12.5471
P/S = 1.7243
P/B = 2.157
P/EG = 0.8831
Revenue TTM = 5.14b USD
EBIT TTM = 515.8m USD
EBITDA TTM = 686.6m USD
Long Term Debt = 14.4m USD (from longTermDebt, last fiscal year)
Short Term Debt = 262.1m USD (from shortTermDebt, last quarter)
Debt = 779.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.06b USD (from netDebt column, last quarter)
Enterprise Value = 7.80b USD (8.86b + Debt 779.9m - CCE 1.84b)
Interest Coverage Ratio = 1659 (Ebit TTM 515.8m / Interest Expense TTM 311.0k)
EV/FCF = 9.65x (Enterprise Value 7.80b / FCF TTM 808.0m)
FCF Yield = 10.36% (FCF TTM 808.0m / Enterprise Value 7.80b)
FCF Margin = 15.71% (FCF TTM 808.0m / Revenue TTM 5.14b)
Net Margin = 7.41% (Net Income TTM 381.1m / Revenue TTM 5.14b)
Gross Margin = 55.33% ((Revenue TTM 5.14b - Cost of Revenue TTM 2.30b) / Revenue TTM)
Gross Margin QoQ = 53.26% (prev 58.12%)
Tobins Q-Ratio = 0.94 (Enterprise Value 7.80b / Total Assets 8.29b)
Interest Expense / Debt = 0.04% (Interest Expense 311.0k / Debt 779.9m)
Taxrate = 30.30% (24.5m / 80.9m)
NOPAT = 359.5m (EBIT 515.8m * (1 - 30.30%))
Current Ratio = 1.57 (Total Current Assets 5.59b / Total Current Liabilities 3.55b)
Debt / Equity = 0.20 (Debt 779.9m / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = -1.55 (Net Debt -1.06b / EBITDA 686.6m)
Debt / FCF = -1.32 (Net Debt -1.06b / FCF TTM 808.0m)
Total Stockholder Equity = 3.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.79% (Net Income 381.1m / Total Assets 8.29b)
RoE = 10.04% (Net Income TTM 381.1m / Total Stockholder Equity 3.80b)
RoCE = 13.53% (EBIT 515.8m / Capital Employed (Equity 3.80b + L.T.Debt 14.4m))
RoIC = 9.45% (NOPAT 359.5m / Invested Capital 3.80b)
WACC = 6.22% (E(8.86b)/V(9.64b) * Re(6.76%) + D(779.9m)/V(9.64b) * Rd(0.04%) * (1-Tc(0.30)))
Discount Rate = 6.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.97%
[DCF] Terminal Value 79.97% ; FCFF base≈721.8m ; Y1≈498.0m ; Y5≈250.9m
[DCF] Fair Price = 51.95 (EV 7.20b - Net Debt -1.06b = Equity 8.27b / Shares 159.1m; r=6.22% [WACC]; 5y FCF grow -36.32% → 2.90% )
EPS Correlation: 49.51 | EPS CAGR: 133.2% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.60 | Revenue CAGR: 19.40% | SUE: 0.66 | # QB: 0
EPS current Year (2026-05-31): EPS=3.57 | Chg7d=+0.000 | Chg30d=+0.131 | Revisions Net=+12 | Growth EPS=+12.7% | Growth Revenue=+11.5%
EPS next Year (2027-05-31): EPS=4.23 | Chg7d=+0.000 | Chg30d=+0.245 | Revisions Net=+14 | Growth EPS=+18.4% | Growth Revenue=+11.0%
[Analyst] Revisions Ratio: +0.86 (13 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.4% (Discount Rate 7.9% - Earnings Yield 4.5%)
[Growth] Growth Spread = +7.6% (Analyst 11.0% - Implied 3.4%)